ART November 30 2006 Agenda [49 Kb PDF]TAP Flyer [100 Kb PDF] Presentations Antiretroviral Drug Resistance Anthony Amoroso, MD Assistant Professor of Medicine University of Maryland School of Medicine Institute of Human Virology Chief of Infectious Diseases, VA Maryland Health Care System [1MB PowerPoint] Experience under the TAP: value added and constraints of Private Public Partnerships in Ghana Richard N. Amenyah, THE WORLD BANK, WASHINGTON DC 30TH NOVEMBER, 2006 [4MB PowerPoint] From HIV Testing to Treatment: Operations Research to Improve ARV Treatment Programs Mark Micek, MD, MPH Health Alliance International University of Washington [1.6MB PowerPoint] Antiretroviral Drug Development: Progress and Challenges Charles Knirsch, MD, MPH VP, New York Site Head, Clinical Research and Development Pfizer, Inc [800Kb PowerPoint] TAP Program Mozambique DREAM, Experience under the TAP: ART regimen for PMTCT and PMTCT+ Treatment Acceleration Program Learning from the experiences gained and the challenges ahead November 30, 2006 Leonardo Palombi and Maria Cristina Marazzi [4MB PowerPoint] Experience under the TAP: Determinants and experience with adherence in Burkina Faso Hospital and Community Sites in Burkina Faso Pascal NIAMBA, Cecile BELOUME [2.5 MB PowerPoint] The TAP and ART Programs in Africa Minimizing risks Maximizing benefits November 30, 2006, A. Voetberg ACTafrica, World Bank [870 Kb PowerPoint] What are we learning about treatment benefits? Damien de Walque Development Research Group Mead Over Center for Global Development The World Bank November 30, 2006 [350 Kb PowerPoint] Experience under the TAP: ART scale up and health systems related bottlenecks in Burkina Faso Treatment Acceleration Program Learning from the experiences gained and the challenges ahead Pascal NIAMBA, Cecile BELOUME [3 MB PowerPoint] ART and Health Systems Lessons from Rwanda Miriam Schneidman ART in Africa Meeting November 30, 2006 [24MB PowerPoint] Panel Questions 58 Kb PowerPoint] Conclusion: Possible solution: Change testing & care for patients in TB treatment [88Kb PowerPoint] [Back to top] |